Xenon Pharmaceuticals
Develops neuroscience medicines for people with neurological and psychiatric disorders
Highlights
- New on EvolcAdded 2026-11-13
About Xenon Pharmaceuticals
Xenon Pharmaceuticals is a neuroscience-focused biopharmaceutical company that discovers, develops and commercializes medicines. Its research includes ion channel science and treatments for conditions such as epilepsy, depression and pain.
The company’s work serves people living with neurological and psychiatric disorders. Its pipeline includes clinical-stage drug candidates, and it has established a development partnership with Neurocrine Biosciences.
Xenon was founded in the 2000s. Its open positions span commercial, clinical development, research operations and corporate functions, with roles listed in Boston, Vancouver and the United States.
Product: Discovery, development and commercialization of therapeutic candidates for neurological and psychiatric disorders.
Jobs at Xenon Pharmaceuticals
More biotech & pharma companies
Zentalis
Clinical-stage oncology company developing an oral WEE1 inhibitor, azenosertib, for platinum-resistant ovarian cancerNew on EvolcZoetis
Animal medicines, vaccines, diagnostics and digital solutions for veterinarians, livestock producers and pet owners4D Molecular Therapeutics
Develops gene therapies using customized viral vectors for patients with retinal and lung diseasesNew on EvolcAcadia Pharmaceuticals
Develops medicines for people with neurological and rare diseasesRemote-friendlyAdaptive Biotechnologies
Immune-receptor sequencing and data products for clinicians and biopharmaceutical companies developing and testing therapiesNew on EvolcAgcbio
Contract development and manufacturing services for biopharmaceutical companies developing biologics and advanced therapiesNew on Evolc
Website technologies
Tools and platforms detected on this company’s website, grouped by purpose. Dates record when Evolc observed them.
Content management
- SanityMedium confidence
- First detected
- Last detected
- Last checked
Detection evidence
- Page markupsoftware structure signature
- Page markupsoftware structure signature
Frontend frameworks
- Next.jsHigh confidence
- First detected
- Last detected
- Last checked
Detection evidence
- Website resourcedeclared script/iframe or software asset
- ReactMedium confidence
- First detected
- Last detected
- Last checked
Detection evidence
- Related technologyimplied by Next.js
- Tailwind CSSMedium confidence
- First detected
- Last detected
- Last checked
Detection evidence
- Page markupsoftware structure signature
- Page markupsoftware structure signature
Hosting
- NetlifyHigh confidence
- First detected
- Last detected
- Last checked
Detection evidence
- Response headerx-nf-request-id
- Response headerx-nf-request-id
- Response headerx-nf-request-id
Website detection does not establish a paid subscription or company-wide use. Tools loaded after consent or sign-in may be missed. “No longer observed” does not prove the company stopped using a tool.